Good agricultural and collection practice for starting materials of herbal origin - Scientific guideline

Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

Human medicines European public assessment report (EPAR): Nurzigma, pridopidine, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

PSUSA/00002052/202410

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 26, Status: Authorised

Pre-authorisation guidance

Human medicines European public assessment report (EPAR): Naveruclif, paclitaxel, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised